share_log

In8bio | 4: Statement of changes in beneficial ownership of securities-Officer Goswami Trishna

SEC announcement ·  Feb 8 22:20
Summary by Moomoo AI
In8bio, Inc. (INAB) has reported a transaction involving Trishna Goswami, the company's Chief Medical Officer. The transaction took place on February 7, 2024. However, the specific details regarding the number of shares, nature of shares, transaction price, and the total value of shares involved in the transaction were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence level of the company's insiders in the firm's prospects.
In8bio, Inc. (INAB) has reported a transaction involving Trishna Goswami, the company's Chief Medical Officer. The transaction took place on February 7, 2024. However, the specific details regarding the number of shares, nature of shares, transaction price, and the total value of shares involved in the transaction were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence level of the company's insiders in the firm's prospects.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more